Overview
Status
Active
Registry date
2007-07-24
Share capital
200 000,00 PLN
Registered address
Grunwaldzka 104, 43-600 Jaworzno, Poland
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 2.39mMedianUSD 1.76mAverageUSD 4.96m
Net profit
This companyUSD -8.23kMedianUSD 17.49kAverageUSD 77.31k
Operating costs
This companyUSD 2.36mMedianUSD 1.72mAverageUSD 4.80m
Assets
This companyUSD 384.01kMedianUSD 495.60kAverageUSD 1.69m
Industry
Bank accounts
Registered as a VAT taxpayer on 2007-07-10. Active
03 1240 1037 1111 0011 5700 4116
05 1600 1462 1088 9865 2000 0004
42 1750 1048 0000 0000 4081 4698
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Wojciech Henryk Zając — President of the Management Board
Manner of representation
The company is represented by each member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 4,000 | $54,024.85 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Wojciech Henryk Zając (61) | Wspólnik posiadający 100 % udziałów w spółce cito spółka z ograniczoną odpowiedzialnością posiadającej 100 % udziałów w spółce mandragora spółka z ograniczoną odpowiedzialnością |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $18,905,980.22 | managementcompany.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Vitasp. z o.o. | $1,873,952.10 | vita-wroclaw.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-WarszawaS.A. | — | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-11-18 | PKD change (Removed: 01.28.Z, 10.41.Z, 10.86.Z, 10.89.Z, 18.20.Z, 20.42.Z, 20.59.Z, 32.50.Z, 46.21.Z, 46.22.Z, 46.51.Z, 46.75.Z, 47.29.Z, 47.62.Z, 49.41.Z, 58.13.Z, 58.19.Z, 58.29.Z, 62.01.Z, 62.02.Z, 62.09.Z, 63.11.Z, 63.12.Z, 72.19.Z, 73.12.B, 73.12.C, 73.12.D, 74.90.Z, 75.00.Z, 85.59.B, 86.10.Z, 86.21.Z, 86.22.Z, 86.90.C, 95.11.Z; Added: 64.99.Z) | |
| 2008-09-24 | PKD change (Removed: 01.11.C, 15.41.C, 15.88.C, 15.89.Z, 22.15.Z, 24.41.Z, 24.42.Z, 24.51.Z, 24.52.Z, 24.63.Z, 24.66.Z, 33.10.A, 36.63.Z, 51.21.Z, 51.22.Z, 51.45.Z, 51.46.Z, 51.55.Z, 52.27.B, 52.31.Z, 52.32.Z, 52.33.Z, 52.61.Z, 60.24.B, 70.20.Z, 73.10.F, 74.40.Z, 74.87.B, 80.42.B, 85.11.Z, 85.12.Z, 85.14.C; Added: 01.28.Z, 10.41.Z, 10.86.Z, 10.89.Z, 18.20.Z, 20.42.Z, 20.59.Z, 21.10.Z, 21.20.Z, 32.50.Z, 46.21.Z, 46.22.Z, 46.45.Z, 46.46.Z, 46.51.Z, 46.75.Z, 47.29.Z, 47.62.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 49.41.Z, 58.13.Z, 58.19.Z, 58.29.Z, 62.01.Z, 62.02.Z, 62.09.Z, 63.11.Z, 63.12.Z, 68.20.Z, 72.19.Z, 73.12.B, 73.12.C, 73.12.D, 74.90.Z, 75.00.Z, 85.59.B, 86.10.Z, 86.21.Z, 86.22.Z, 86.90.C, 95.11.Z) | |
| 2007-07-24 | Entered in the register |
FAQ
The main business activity of Mandragora focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on July 24, 2007.
The headquarters is located at: Grunwaldzka 104, 43-600 Jaworzno.
The share capital of the company is PLN 200,000 (approx. $54,025).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $2,004,596, representing an increase of 21.7% compared to 2023.
No, the company recorded a net loss of $41,606 in 2024. For comparison, in 2023 the loss was $79,778, meaning the company reduced its loss by 50.5%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,551,054 in 2024, representing 78% of all operating expenses.
Last updated: 2026-07-17